Cite
HARVARD Citation
Kuemmerle-Deschner, J. et al. (2015). Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: results from beta-confident registry. Pediatric rheumatology online journal. 13 (1), pp. 1-2. [Online].